U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018922

Expand all

LODINE (ETODOLAC)
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: ETODOLAC
Proprietary Name: LODINE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N018922
Product Number: 002
Approval Date: Jan 31, 1991
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
LODINE (ETODOLAC)
300MG
Marketing Status: Discontinued
Active Ingredient: ETODOLAC
Proprietary Name: LODINE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N018922
Product Number: 003
Approval Date: Jan 31, 1991
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
LODINE (ETODOLAC)
400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: ETODOLAC
Proprietary Name: LODINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N018922
Product Number: 004
Approval Date: Jul 29, 1993
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
LODINE (ETODOLAC)
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: ETODOLAC
Proprietary Name: LODINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N018922
Product Number: 005
Approval Date: Jun 28, 1996
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top